It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Explore Visa cards that provide rewards without the burden of annual fees. Enjoy benefits while saving money.
22,257 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Between Dec 31, 2025 and July 10, 2026, the Global X AI & Technology ETF rose about 24.74%, while Arista Networks cli...
Amazon executed a $25 billion debt sale that drew heavy demand and extended its growth funding runway. Here are three...
Navigate Neptune's Q4 2025 performance, understand margin dynamics, and gauge 2026 guidance. This practical guide exp...
Addy AI announced a strategic integration with ICE Mortgage Technology’s Encompass system to automate loan officer wo...
A major fund just disclosed a sizable stake in Tango Therapeutics (TNGX), totaling about $9.5 million. This move shin...
Anthropic’s latest coding assistant is reshaping how enterprises buy software, potentially ending seat-based licenses...
NASA issued a comprehensive review of Boeing's Starliner program, yet the agency has not pulled the plug. Here’s how ...
Three energy-focused funds are delivering yields near 7% or higher, outpacing the 10-year Treasury as markets rebalan...
As AI shifts the tech landscape, Microsoft sits at the center of the action. This guide breaks down whether will micr...
Anduril CEO Brian Schimpf has quietly steered the defense-tech startup from desert days to a major defense contractor...
As listings climb in spring 2026, inventory growth making housing is reshaping affordability for buyers, offering mor...